Isavuconazole in the treatment of pulmonary mucormycosis in children undergoing hematopoietic stem cell transplantation:a case report
This paper reports a case of clinical practice of using isavuconazole to treat pulmonary mucormycosis in a child with acute lymphocytic leukemia during the perioperative period of hematopoietic stem cell transplantation.Clinical pharmacists participated in consultations and suggested the use of isavuconazole to treat pulmonary mucormycosis based on the patient's condition,determined the medication dosage for children,and monitored safety and effectiveness during treatment.After treatment,the pulmonary lesions in the child improved.As a new drug,there was limited experience of isavuconazole in children's use.Clinical pharmacists have consulted literature,formulated medication plans,and implemented pharmaceutical monitoring to ensure the rational and safe use of medication in children.